BioAge Labs, Inc. (BIOA) stock
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.10−0.12 (-2.30%)
Close on Nov 17, 2026Market cap $234.07MP/E –Yield –
BioAge Labs profit margin
Profit margin (net margin) is net income as a percentage of revenue.
BioAge Labs's profit margin for the twelve months ending Jun 30, 2026 was -912.3%. For fiscal 2025 it was -896.1%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -896.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1064.7% | −170.8 |
| Q1 FY2026 | Mar 31, 2026 | -802.8% | +88.2 |
| Q4 FY2025 | Dec 31, 2025 | -842.9% | – |
| Q3 FY2025 | Sep 30, 2025 | -982.0% | – |
| Q2 FY2025 | Jun 30, 2025 | -894.0% | – |
| Q1 FY2025 | Mar 31, 2025 | -891.0% | – |
See a number that looks wrong?